{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:38:59Z","timestamp":1792535939203,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"DOI":"10.1007\/s00408-026-00954-3","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:02:59Z","timestamp":1792490579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MUC5B\/TGF-\u03b2\/KL-6 Signaling in Idiopathic Pulmonary Fibrosis: Genetic Susceptibility to Profibrotic Progression and Clinical Perspectives"],"prefix":"10.1007","volume":"204","author":[{"given":"Sreedhara Muppana","family":"Venkatesharao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbu","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"954_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.resinv.2020.04.002","volume":"58","author":"DS Glass","year":"2020","unstructured":"Glass DS, Grossfeld D, Renna HA et al (2020) Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches. Respir Investig 58:320\u2013335. https:\/\/doi.org\/10.1016\/j.resinv.2020.04.002","journal-title":"Respir Investig"},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/medsci6030073","volume":"6","author":"M Aburto","year":"2018","unstructured":"Aburto M, Herr\u00e1ez I, Iturbe D, Jim\u00e9nez-Romero A (2018) Diagnosis of idiopathic pulmonary fibrosis: differential diagnosis. Med Sci 6:73. https:\/\/doi.org\/10.3390\/medsci6030073","journal-title":"Med Sci"},{"key":"954_CR3","doi-asserted-by":"publisher","first-page":"108757","DOI":"10.1016\/j.pharmthera.2024.108757","volume":"265","author":"W Lu","year":"2025","unstructured":"Lu W, Teoh A, Waters M et al (2025) Pathology of idiopathic pulmonary fibrosis with particular focus on vascular endothelium and epithelial injury and their therapeutic potential. Pharmacol Ther 265:108757. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108757","journal-title":"Pharmacol Ther"},{"key":"954_CR4","doi-asserted-by":"publisher","first-page":"797292","DOI":"10.3389\/fphar.2021.797292","volume":"12","author":"Q Mei","year":"2022","unstructured":"Mei Q, Liu Z, Zuo H et al (2022) Idiopathic pulmonary fibrosis: an update on pathogenesis. Front Pharmacol 12:797292. https:\/\/doi.org\/10.3389\/fphar.2021.797292","journal-title":"Front Pharmacol"},{"key":"954_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1152\/physrev.00024.2025","volume":"106","author":"CR Kliment","year":"2026","unstructured":"Kliment CR, Gurkar AU, C\u00e1rdenes N et al (2026) Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease. Physiol Rev 106:1535\u20131591. https:\/\/doi.org\/10.1152\/physrev.00024.2025","journal-title":"Physiol Rev"},{"key":"954_CR6","doi-asserted-by":"publisher","first-page":"16481","DOI":"10.3390\/ijms242216481","volume":"24","author":"S Gandhi","year":"2023","unstructured":"Gandhi S, Tonelli R, Murray M et al (2023) Environmental causes of idiopathic pulmonary fibrosis. Int J Mol Sci 24:16481. https:\/\/doi.org\/10.3390\/ijms242216481","journal-title":"Int J Mol Sci"},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"55981","DOI":"10.1007\/s11356-021-16056-x","volume":"28","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee S, Dasgupta S, Mishra PK, Chaudhury K (2021) Air pollution-induced epigenetic changes: disease development and a possible link with hypersensitivity pneumonitis. Environ Sci Pollut Res Int 28:55981\u201356002. https:\/\/doi.org\/10.1007\/s11356-021-16056-x","journal-title":"Environ Sci Pollut Res Int"},{"key":"954_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001901","author":"Q-Q Zhu","year":"2015","unstructured":"Zhu Q-Q, Zhang X-L, Zhang S-M et al (2015) Association between the MUC5B promoter polymorphism rs35705950 and idiopathic pulmonary fibrosis: a meta-analysis and trial sequential analysis in caucasian and asian populations. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000001901","journal-title":"Medicine"},{"key":"954_CR9","doi-asserted-by":"publisher","first-page":"10159","DOI":"10.3389\/ti.2022.10159","volume":"35","author":"T Goos","year":"2022","unstructured":"Goos T, Verleden SE, De Sadeleer LJ et al (2022) The MUC5B promoter polymorphism is not associated with non-ILD chronic respiratory diseases or post-transplant outcome. Transpl Int 35:10159. https:\/\/doi.org\/10.3389\/ti.2022.10159","journal-title":"Transpl Int"},{"key":"954_CR10","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.7150\/ijms.113226","volume":"22","author":"J Liu","year":"2025","unstructured":"Liu J, Yi Z, Chen T et al (2025) An overview of the role of genetic factors in idiopathic pulmonary fibrosis: insights from epidemiology to prognosis. Int J Med Sci 22:2992\u20133006. https:\/\/doi.org\/10.7150\/ijms.113226","journal-title":"Int J Med Sci"},{"key":"954_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7150\/ijms.80358","volume":"20","author":"D Ding","year":"2023","unstructured":"Ding D, Gao R, Xue Q et al (2023) Genomic fingerprint associated with familial idiopathic pulmonary fibrosis: a review. Int J Med Sci 20:329\u2013345. https:\/\/doi.org\/10.7150\/ijms.80358","journal-title":"Int J Med Sci"},{"key":"954_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.matbio.2018.03.015","volume":"68\u201369","author":"A Burman","year":"2018","unstructured":"Burman A, Tanjore H, Blackwell TS (2018) Endoplasmic reticulum stress in pulmonary fibrosis. Matrix Biol 68\u201369:355\u2013365. https:\/\/doi.org\/10.1016\/j.matbio.2018.03.015","journal-title":"Matrix Biol"},{"key":"954_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13023-026-04210-y","volume":"21","author":"G Francesca","year":"2026","unstructured":"Francesca G, Michele S, Anna P et al (2026) Epidemiology of idiopathic pulmonary fibrosis: a population registry-based study. Orphanet J Rare Dis 21:57. https:\/\/doi.org\/10.1186\/s13023-026-04210-y","journal-title":"Orphanet J Rare Dis"},{"key":"954_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.rmcr.2018.12.005","volume":"26","author":"SR Sousa","year":"2019","unstructured":"Sousa SR, Caetano Mota P, Melo N et al (2019) Heterozygous TERT gene mutation associated with familial idiopathic pulmonary fibrosis. Respir Med Case Rep 26:118\u2013122. https:\/\/doi.org\/10.1016\/j.rmcr.2018.12.005","journal-title":"Respir Med Case Rep"},{"key":"954_CR15","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3390\/ijms26052218","volume":"26","author":"KB Lewandowska","year":"2025","unstructured":"Lewandowska KB, Lechowicz U, Ro\u017cy A et al (2025) MUC5B Polymorphism in patients with idiopathic pulmonary fibrosis\u2014does it really matter? Int J Mol Sci 26:2218. https:\/\/doi.org\/10.3390\/ijms26052218","journal-title":"Int J Mol Sci"},{"key":"954_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1164\/rccm.201804-0734OC","volume":"199","author":"K Okuda","year":"2019","unstructured":"Okuda K, Chen G, Subramani DB et al (2019) Localization of secretory mucins MUC5AC and MUC5B in normal\/healthy human airways. Am J Respir Crit Care Med 199:715\u2013727. https:\/\/doi.org\/10.1164\/rccm.201804-0734OC","journal-title":"Am J Respir Crit Care Med"},{"key":"954_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12931-018-0901-1","volume":"19","author":"R Imberti","year":"2018","unstructured":"Imberti R, Garavaglia ML, Verduci I et al (2018) Antiestrogen- and tamoxifen-induced effects on calcium-activated chloride currents in epithelial cells carrying the \u2206F508-CFTR point mutation. Respir Res 19:198. https:\/\/doi.org\/10.1186\/s12931-018-0901-1","journal-title":"Respir Res"},{"key":"954_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1164\/rccm.201509-1872LE","volume":"193","author":"Y Nakano","year":"2016","unstructured":"Nakano Y, Yang IV, Walts AD et al (2016) MUC5B promoter variant rs35705950 affects MUC5B expression in the distal airways in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193:464\u2013466. https:\/\/doi.org\/10.1164\/rccm.201509-1872LE","journal-title":"Am J Respir Crit Care Med"},{"key":"954_CR19","doi-asserted-by":"publisher","first-page":"L329","DOI":"10.1152\/ajplung.00061.2022","volume":"323","author":"T Okamoto","year":"2022","unstructured":"Okamoto T, Dobrinskikh E, Hennessy CE et al (2022) Muc5b plays a role in the development of inflammation and fibrosis in hypersensitivity pneumonitis induced by Saccharopolyspora rectivirgula. Am J Physiol-Lung Cell Mol Physiol 323:L329\u2013L337. https:\/\/doi.org\/10.1152\/ajplung.00061.2022","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"954_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/diagnostics11050762","volume":"11","author":"E Baratella","year":"2021","unstructured":"Baratella E, Ruaro B, Giudici F et al (2021) Evaluation of correlations between genetic variants and high-resolution computed tomography patterns in idiopathic pulmonary fibrosis. Diagnostics 11:762. https:\/\/doi.org\/10.3390\/diagnostics11050762","journal-title":"Diagnostics"},{"key":"954_CR21","doi-asserted-by":"publisher","first-page":"e26623","DOI":"10.1016\/j.heliyon.2024.e26623","volume":"10","author":"I Gay\u00e1 Garc\u00eda-Manso","year":"2024","unstructured":"Gay\u00e1 Garc\u00eda-Manso I, Arenas Jim\u00e9nez J, Hern\u00e1ndez Blasco L et al (2024) Radiological usual interstitial pneumonia pattern is associated with two-year mortality in patients with idiopathic pulmonary fibrosis. Heliyon 10:e26623. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26623","journal-title":"Heliyon"},{"key":"954_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1165\/rcmb.2017-0046OC","volume":"57","author":"BA Helling","year":"2017","unstructured":"Helling BA, Gerber AN, Kadiyala V et al (2017) Regulation of MUC5B expression in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 57:91\u201399. https:\/\/doi.org\/10.1165\/rcmb.2017-0046OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"954_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S2213-2600(17)30216-3","volume":"5","author":"B Ley","year":"2017","unstructured":"Ley B, Newton CA, Arnould I et al (2017) The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis. Lancet Respir Med 5:639\u2013647. https:\/\/doi.org\/10.1016\/S2213-2600(17)30216-3","journal-title":"Lancet Respir Med"},{"key":"954_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13023-021-01750-3","volume":"16","author":"F Bonella","year":"2021","unstructured":"Bonella F, Campo I, Zorzetto M et al (2021) Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF. Orphanet J Rare Dis 16:111. https:\/\/doi.org\/10.1186\/s13023-021-01750-3","journal-title":"Orphanet J Rare Dis"},{"key":"954_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43168-020-00015-0","volume":"14","author":"HAA Yusuf","year":"2020","unstructured":"Yusuf HAA, Galal M, Kaddah S et al (2020) A preliminary study: MUC5B promoter polymorphism and its association with IPF. Egypt J Bronchol 14:18. https:\/\/doi.org\/10.1186\/s43168-020-00015-0","journal-title":"Egypt J Bronchol"},{"key":"954_CR26","doi-asserted-by":"publisher","first-page":"1544864","DOI":"10.3389\/fgene.2025.1544864","volume":"16","author":"A Mouawad","year":"2025","unstructured":"Mouawad A, Chouery E, Chebly A et al (2025) Association of the MUC5B promoter polymorphism with idiopathic pulmonary fibrosis in a lebanese cohort. Front Genet 16:1544864. https:\/\/doi.org\/10.3389\/fgene.2025.1544864","journal-title":"Front Genet"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"24007","DOI":"10.1038\/s41598-021-03533-z","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li W, Luo Z, Chen Y (2021) The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis. Sci Rep 11:24007. https:\/\/doi.org\/10.1038\/s41598-021-03533-z","journal-title":"Sci Rep"},{"key":"954_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/resp.14440","volume":"28","author":"JJ van der Vis","year":"2023","unstructured":"van der Vis JJ, Prasse A, Renzoni EA et al (2023) MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis. Respirology 28:455\u2013464. https:\/\/doi.org\/10.1111\/resp.14440","journal-title":"Respirology"},{"key":"954_CR29","doi-asserted-by":"publisher","first-page":"14532","DOI":"10.1038\/ncomms14532","volume":"8","author":"MJ Schafer","year":"2017","unstructured":"Schafer MJ, White TA, Iijima K et al (2017) Cellular senescence mediates fibrotic pulmonary disease. Nat Commun 8:14532. https:\/\/doi.org\/10.1038\/ncomms14532","journal-title":"Nat Commun"},{"key":"954_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s43152-022-00038-3","volume":"3","author":"S Deinhardt-Emmer","year":"2022","unstructured":"Deinhardt-Emmer S, Le Saux CJ (2022) The aging microenvironment in lung fibrosis. Curr Tissue Microenviron Rep 3:67\u201376. https:\/\/doi.org\/10.1007\/s43152-022-00038-3","journal-title":"Curr Tissue Microenviron Rep"},{"key":"954_CR31","doi-asserted-by":"publisher","first-page":"15189","DOI":"10.3390\/ijms232315189","volume":"23","author":"I Udroiu","year":"2022","unstructured":"Udroiu I, Marinaccio J, Sgura A (2022) Many functions of telomerase components: certainties, doubts, and inconsistencies. Int J Mol Sci 23:15189. https:\/\/doi.org\/10.3390\/ijms232315189","journal-title":"Int J Mol Sci"},{"key":"954_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2609","volume":"45","author":"TE Fingerlin","year":"2013","unstructured":"Fingerlin TE, Murphy E, Zhang W et al (2013) Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 45:613\u2013620. https:\/\/doi.org\/10.1038\/ng.2609","journal-title":"Nat Genet"},{"key":"954_CR33","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/medicina60121967","volume":"60","author":"S Cerri","year":"2024","unstructured":"Cerri S, Manzini E, Nori O et al (2024) Genetic risk factors in idiopathic and non-idiopathic interstitial lung disease: similarities and differences. Med (Mex) 60:1967. https:\/\/doi.org\/10.3390\/medicina60121967","journal-title":"Med (Mex)"},{"key":"954_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1513\/AnnalsATS.201808-508CME","volume":"16","author":"AM Courtwright","year":"2019","unstructured":"Courtwright AM, El-Chemaly S (2019) Telomeres in interstitial lung disease: the short and the long of it. Ann Am Thorac Soc 16:175\u2013181. https:\/\/doi.org\/10.1513\/AnnalsATS.201808-508CME","journal-title":"Ann Am Thorac Soc"},{"key":"954_CR35","doi-asserted-by":"publisher","first-page":"739810","DOI":"10.3389\/fmed.2021.739810","volume":"8","author":"K Zhang","year":"2021","unstructured":"Zhang K, Xu L, Cong Y-S (2021) Telomere dysfunction in idiopathic pulmonary fibrosis. Front Med 8:739810. https:\/\/doi.org\/10.3389\/fmed.2021.739810","journal-title":"Front Med"},{"key":"954_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.31557\/APJCP.2020.21.3.667","volume":"21","author":"M Arimura-Omori","year":"2020","unstructured":"Arimura-Omori M, Kiyohara C, Yanagihara T et al (2020) Association between telomere-related polymorphisms and the risk of IPF and COPD as a precursor lesion of lung cancer: findings from the fukuoka tobacco-related lung disease (FOLD) registry. Asian Pac J Cancer Prev APJCP 21:667\u2013673. https:\/\/doi.org\/10.31557\/APJCP.2020.21.3.667","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"954_CR37","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.3390\/jcm11236893","volume":"11","author":"A Mulet","year":"2022","unstructured":"Mulet A, Signes-Costa J (2022) Idiopathic pulmonary fibrosis and telomeres. J Clin Med 11:6893. https:\/\/doi.org\/10.3390\/jcm11236893","journal-title":"J Clin Med"},{"key":"954_CR38","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold MA, Wise AL, Speer MC et al (2011) A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364:1503\u20131512. https:\/\/doi.org\/10.1056\/NEJMoa1013660","journal-title":"N Engl J Med"},{"key":"954_CR39","doi-asserted-by":"publisher","first-page":"e70621","DOI":"10.1371\/journal.pone.0070621","volume":"8","author":"R Borie","year":"2013","unstructured":"Borie R, Crestani B, Dieude P et al (2013) The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS ONE 8:e70621. https:\/\/doi.org\/10.1371\/journal.pone.0070621","journal-title":"PLoS ONE"},{"key":"954_CR40","first-page":"14953","volume":"8","author":"H Jiang","year":"2015","unstructured":"Jiang H, Hu Y, Shang L et al (2015) Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis. Int J Clin Exp Pathol 8:14953\u201314958","journal-title":"Int J Clin Exp Pathol"},{"key":"954_CR41","doi-asserted-by":"publisher","first-page":"e104919","DOI":"10.1371\/journal.pone.0104919","volume":"9","author":"C Wang","year":"2014","unstructured":"Wang C, Zhuang Y, Guo W et al (2014) Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males. PLoS ONE 9:e104919. https:\/\/doi.org\/10.1371\/journal.pone.0104919","journal-title":"PLoS ONE"},{"key":"954_CR42","doi-asserted-by":"publisher","first-page":"e18743064421488","DOI":"10.2174\/0118743064421488251017061020","volume":"20","author":"F Fachrucha","year":"2026","unstructured":"Fachrucha F, Syuaib FI, Purwono A et al (2026) Shortened telomere length as a risk factor for idiopathic pulmonary fibrosis: a meta-analysis. Open Respir Med J 20:e18743064421488. https:\/\/doi.org\/10.2174\/0118743064421488251017061020","journal-title":"Open Respir Med J"},{"key":"954_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.739810","author":"K Zhang","year":"2021","unstructured":"Zhang K, Xu L, Cong Y-S (2021) Telomere dysfunction in idiopathic pulmonary fibrosis. Front Med. https:\/\/doi.org\/10.3389\/fmed.2021.739810","journal-title":"Front Med"},{"key":"954_CR44","doi-asserted-by":"publisher","first-page":"00003","DOI":"10.1183\/23120541.00003-2020","volume":"6","author":"AM Courtwright","year":"2020","unstructured":"Courtwright AM, Lamattina AM, Takahashi M et al (2020) Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival. ERJ Open Res 6:00003\u201302020. https:\/\/doi.org\/10.1183\/23120541.00003-2020","journal-title":"ERJ Open Res"},{"key":"954_CR45","doi-asserted-by":"publisher","first-page":"2401545","DOI":"10.1183\/13993003.01545-2024","volume":"65","author":"PD Shah","year":"2025","unstructured":"Shah PD, Armanios M (2025) Viewpoint: Pre- and post-lung transplant considerations for patients with ultra-short telomere length. Eur Respir J 65:2401545. https:\/\/doi.org\/10.1183\/13993003.01545-2024","journal-title":"Eur Respir J"},{"key":"954_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1747200","author":"AP Hern\u00e1ndez Cristancho","year":"2026","unstructured":"Hern\u00e1ndez Cristancho AP, Planas-Cerezales L, Molina-Molina M et al (2026) Familial interstitial lung disease: emerging insights into screening and genetic risk. Front Med. https:\/\/doi.org\/10.3389\/fmed.2026.1747200","journal-title":"Front Med"},{"key":"954_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fmed.2017.00154","volume":"4","author":"A Kaur","year":"2017","unstructured":"Kaur A, Mathai SK, Schwartz DA (2017) Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment. Front Med 4:154. https:\/\/doi.org\/10.3389\/fmed.2017.00154","journal-title":"Front Med"},{"key":"954_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.698905","author":"S Wang","year":"2021","unstructured":"Wang S, Li Z, Wang X et al (2021) The role of pulmonary surfactants in the treatment of acute respiratory distress syndrome in COVID-19. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.698905","journal-title":"Front Pharmacol"},{"key":"954_CR49","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/humu.24476","volume":"43","author":"RM Sutton","year":"2022","unstructured":"Sutton RM, Bittar HT, Sullivan DI et al (2022) Rare surfactant-related variants in familial and sporadic pulmonary fibrosis. Hum Mutat 43:2091\u20132101. https:\/\/doi.org\/10.1002\/humu.24476","journal-title":"Hum Mutat"},{"key":"954_CR50","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3389\/fimmu.2018.02256","volume":"9","author":"Z Lin","year":"2018","unstructured":"Lin Z, Thorenoor N, Wu R et al (2018) Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis. Front Immunol 9:2256. https:\/\/doi.org\/10.3389\/fimmu.2018.02256","journal-title":"Front Immunol"},{"key":"954_CR51","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.chest.2021.06.037","volume":"160","author":"D Zhang","year":"2021","unstructured":"Zhang D, Newton CA (2021) Familial pulmonary fibrosis. Chest 160:1764\u20131773. https:\/\/doi.org\/10.1016\/j.chest.2021.06.037","journal-title":"Chest"},{"key":"954_CR52","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.3390\/ijms24087554","volume":"24","author":"X Yang","year":"2023","unstructured":"Yang X, Rapp CK, Li Y et al (2023) Quantifying functional impairment of ABCA3 variants associated with interstitial lung disease. Int J Mol Sci 24:7554. https:\/\/doi.org\/10.3390\/ijms24087554","journal-title":"Int J Mol Sci"},{"key":"954_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ped4.12020","volume":"2","author":"L Denman","year":"2018","unstructured":"Denman L, Yonker LM, Kinane TB (2018) The classification of ATP-binding cassette subfamily A member 3 mutations using the cystic fibrosis transmembrane conductance regulator classification system. Pediatr Investig 2:17\u201324. https:\/\/doi.org\/10.1002\/ped4.12020","journal-title":"Pediatr Investig"},{"key":"954_CR54","doi-asserted-by":"publisher","first-page":"766719","DOI":"10.3389\/fimmu.2021.766719","volume":"12","author":"J Floros","year":"2021","unstructured":"Floros J, Tsotakos N (2021) Differential regulation of human surfactant protein a genes, SFTPA1 and SFTPA2, and their corresponding variants. Front Immunol 12:766719. https:\/\/doi.org\/10.3389\/fimmu.2021.766719","journal-title":"Front Immunol"},{"key":"954_CR55","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/MOP.0000000000000751","volume":"31","author":"LM Nogee","year":"2019","unstructured":"Nogee LM (2019) Genetic causes of surfactant protein abnormalities. Curr Opin Pediatr 31:330\u2013339. https:\/\/doi.org\/10.1097\/MOP.0000000000000751","journal-title":"Curr Opin Pediatr"},{"key":"954_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41536-026-00455-0","volume":"11","author":"C Predella","year":"2026","unstructured":"Predella C, Lapsley L, Ni K et al (2026) Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice. Npj Regen Med 11:11. https:\/\/doi.org\/10.1038\/s41536-026-00455-0","journal-title":"Npj Regen Med"},{"key":"954_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11401-5","author":"K Kannan","year":"2025","unstructured":"Kannan K, Mohan S (2025) Targeting mTORC1\/TGFB1 signaling with a novel Bergapten-Esculetin combination: a computational and experimental approach in idiopathic pulmonary fibrosis. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-025-11401-5","journal-title":"Mol Divers"},{"key":"954_CR58","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"Y-J Guo","year":"2020","unstructured":"Guo Y-J, Pan W-W, Liu S-B et al (2020) ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19:1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454","journal-title":"Exp Ther Med"},{"key":"954_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J et al (2022) Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7:3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6","journal-title":"Signal Transduct Target Ther"},{"key":"954_CR60","doi-asserted-by":"publisher","first-page":"4537256","DOI":"10.1155\/2022\/4537256","volume":"2022","author":"F Shi","year":"2022","unstructured":"Shi F, Li L (2022) Phosphatidylinositol 3-Kinase\/Protein Kinase B\/Mammalian target of the rapamycin pathway-related protein expression in lung squamous cell carcinoma and its correlation with lymph node metastasis. J Oncol 2022:4537256. https:\/\/doi.org\/10.1155\/2022\/4537256","journal-title":"J Oncol"},{"key":"954_CR61","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1165\/rcmb.2017-0075OC","volume":"58","author":"RS Knipe","year":"2018","unstructured":"Knipe RS, Probst CK, Lagares D et al (2018) The rho kinase isoforms ROCK1 and ROCK2 Each contribute to the development of experimental pulmonary fibrosis. Am J Respir Cell Mol Biol 58:471\u2013481. https:\/\/doi.org\/10.1165\/rcmb.2017-0075OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"954_CR62","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antiox15010142","volume":"15","author":"D Xu","year":"2026","unstructured":"Xu D, Wang Q, Lyu M et al (2026) The mechanism of oxidative stress in pulmonary fibrosis and research progress. Antioxidants 15:142. https:\/\/doi.org\/10.3390\/antiox15010142","journal-title":"Antioxidants"},{"key":"954_CR63","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/ijms20040857","volume":"20","author":"L Sisinni","year":"2019","unstructured":"Sisinni L, Pietrafesa M, Lepore S et al (2019) Endoplasmic reticulum stress and unfolded protein response in breast cancer: the balance between apoptosis and autophagy and its role in drug resistance. Int J Mol Sci 20:857. https:\/\/doi.org\/10.3390\/ijms20040857","journal-title":"Int J Mol Sci"},{"key":"954_CR64","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3390\/biomedicines11092517","volume":"11","author":"A Elmore","year":"2023","unstructured":"Elmore A, Almuntashiri A, Wang X et al (2023) Circulating surfactant protein D: A biomarker for acute lung injury? Biomedicines 11:2517. https:\/\/doi.org\/10.3390\/biomedicines11092517","journal-title":"Biomedicines"},{"key":"954_CR65","doi-asserted-by":"publisher","first-page":"114472","DOI":"10.1016\/j.biopha.2023.114472","volume":"161","author":"L Shan","year":"2023","unstructured":"Shan L, Wang F, Zhai D et al (2023) Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomed Pharmacother 161:114472. https:\/\/doi.org\/10.1016\/j.biopha.2023.114472","journal-title":"Biomed Pharmacother"},{"key":"954_CR66","doi-asserted-by":"publisher","first-page":"810338","DOI":"10.3389\/fimmu.2022.810338","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, He Y, Chen S et al (2022) S100A12 as biomarker of disease severity and prognosis in patients with idiopathic pulmonary fibrosis. Front Immunol 13:810338. https:\/\/doi.org\/10.3389\/fimmu.2022.810338","journal-title":"Front Immunol"},{"key":"954_CR67","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.3390\/biomedicines11102796","volume":"11","author":"I Tomos","year":"2023","unstructured":"Tomos I, Roussis I, Matthaiou AM, Dimakou K (2023) Molecular and genetic biomarkers in idiopathic pulmonary fibrosis: where are we now? Biomedicines 11:2796. https:\/\/doi.org\/10.3390\/biomedicines11102796","journal-title":"Biomedicines"},{"key":"954_CR68","doi-asserted-by":"publisher","first-page":"e792","DOI":"10.1002\/mco2.792","volume":"5","author":"S Pan","year":"2024","unstructured":"Pan S, Yin L, Liu J et al (2024) Metabolomics-driven approaches for identifying therapeutic targets in drug discovery. MedComm 5:e792. https:\/\/doi.org\/10.1002\/mco2.792","journal-title":"MedComm"},{"key":"954_CR69","doi-asserted-by":"publisher","first-page":"492960","DOI":"10.1155\/2012\/492960","volume":"2012","author":"S Chiba","year":"2012","unstructured":"Chiba S, Ohta H, Abe K et al (2012) The diagnostic value of the interstitial biomarkers KL-6 and SP-D for the degree of fibrosis in combined pulmonary fibrosis and emphysema. Pulm Med 2012:492960. https:\/\/doi.org\/10.1155\/2012\/492960","journal-title":"Pulm Med"},{"key":"954_CR70","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/10408363.2017.1410520","volume":"54","author":"JL Garc\u00eda-Gim\u00e9nez","year":"2017","unstructured":"Garc\u00eda-Gim\u00e9nez JL, Seco-Cervera M, Tollefsbol TO et al (2017) Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory. Crit Rev Clin Lab Sci 54:529\u2013550. https:\/\/doi.org\/10.1080\/10408363.2017.1410520","journal-title":"Crit Rev Clin Lab Sci"},{"key":"954_CR71","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.pccm.2024.04.003","volume":"2","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Peng F, Zhou Y (2024) Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction. Chin Med J Pulm Crit Care Med 2:72\u201379. https:\/\/doi.org\/10.1016\/j.pccm.2024.04.003","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"954_CR72","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1042\/CS20190249","volume":"133","author":"F Liu","year":"2019","unstructured":"Liu F, Bayliss G, Zhuang S (2019) Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases. Clin Sci Lond Engl 1979 133:1309\u20131320. https:\/\/doi.org\/10.1042\/CS20190249","journal-title":"Clin Sci Lond Engl 1979"},{"key":"954_CR73","doi-asserted-by":"publisher","first-page":"121048","DOI":"10.1016\/j.lfs.2022.121048","volume":"309","author":"SA Antar","year":"2022","unstructured":"Antar SA, Saleh MA, Al-Karmalawy AA (2022) Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and\/or anti-SARS-CoV-2. Life Sci 309:121048. https:\/\/doi.org\/10.1016\/j.lfs.2022.121048","journal-title":"Life Sci"},{"key":"954_CR74","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12032-025-02755-9","volume":"42","author":"K Kannan","year":"2025","unstructured":"Kannan K, Mohan S (2025) Targeting exon mutations in NSCLC: clinical insights into LAG-3, TIM-3 pathways, and advances in fourth-generation EGFR-TKIs. Med Oncol Northwood Lond Engl 42:196. https:\/\/doi.org\/10.1007\/s12032-025-02755-9","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"954_CR75","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3892\/etm.2019.7579","volume":"18","author":"F Feng","year":"2019","unstructured":"Feng F, Zhang J, Wang Z et al (2019) Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis. Exp Ther Med 18:802\u2013816. https:\/\/doi.org\/10.3892\/etm.2019.7579","journal-title":"Exp Ther Med"},{"key":"954_CR76","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.omtm.2021.01.003","volume":"20","author":"MJR Ruigrok","year":"2021","unstructured":"Ruigrok MJR, Frijlink HW, Melgert BN et al (2021) Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions. Mol Ther Methods Clin Dev 20:483\u2013496. https:\/\/doi.org\/10.1016\/j.omtm.2021.01.003","journal-title":"Mol Ther Methods Clin Dev"},{"key":"954_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1777480","author":"Y Song","year":"2026","unstructured":"Song Y, Wu X, Tian H, Liu Z (2026) Maintenance and disruption of mucous barrier homeostasis: the critical role of MUC5AC\/MUC5B balance in airway diseases. Front Med. https:\/\/doi.org\/10.3389\/fmed.2026.1777480","journal-title":"Front Med"},{"key":"954_CR78","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1038\/s41467-018-07768-9","volume":"9","author":"LA Hancock","year":"2018","unstructured":"Hancock LA, Hennessy CE, Solomon GM et al (2018) Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice. Nat Commun 9:5363. https:\/\/doi.org\/10.1038\/s41467-018-07768-9","journal-title":"Nat Commun"},{"key":"954_CR79","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/biomedicines13112656","volume":"13","author":"G Raineri","year":"2025","unstructured":"Raineri G, Samarelli AV, Tonelli R et al (2025) Predicting and treating pulmonary fibrosis with proteomic biomarker investigations. Biomedicines 13:2656. https:\/\/doi.org\/10.3390\/biomedicines13112656","journal-title":"Biomedicines"},{"key":"954_CR80","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/antiox10060967","volume":"10","author":"MC Ten\u00f3rio dos","year":"2021","unstructured":"Ten\u00f3rio MC dos, Graciliano S, Moura NG FA, et al (2021) N-Acetylcysteine (NAC): impacts on human health. Antioxidants 10:967. https:\/\/doi.org\/10.3390\/antiox10060967","journal-title":"Antioxidants"},{"key":"954_CR81","doi-asserted-by":"publisher","first-page":"838449","DOI":"10.3389\/fphar.2022.838449","volume":"13","author":"FE Herrmann","year":"2022","unstructured":"Herrmann FE, Hesslinger C, Wollin L, Nickolaus P (2022) BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis. Front Pharmacol 13:838449. https:\/\/doi.org\/10.3389\/fphar.2022.838449","journal-title":"Front Pharmacol"},{"key":"954_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012785.pub2","author":"H Barnes","year":"2019","unstructured":"Barnes H, Yeoh H, Fothergill T et al (2019) Prostacyclin for pulmonary arterial hypertension. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012785.pub2. 2019:CD012785","journal-title":"Cochrane Database Syst Rev"},{"key":"954_CR83","doi-asserted-by":"publisher","first-page":"e001026","DOI":"10.1136\/bmjresp-2021-001026","volume":"8","author":"TJ Corte","year":"2021","unstructured":"Corte TJ, Lancaster L, Swigris JJ et al (2021) Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). BMJ Open Respir Res 8:e001026. https:\/\/doi.org\/10.1136\/bmjresp-2021-001026","journal-title":"BMJ Open Respir Res"},{"key":"954_CR84","doi-asserted-by":"publisher","first-page":"e003038","DOI":"10.1136\/bmjresp-2024-003038","volume":"12","author":"T Maher","year":"2025","unstructured":"Maher T, Song JW, Kramer MR et al (2025) Phase 2 study design and analysis approach for BBT-877: an autotaxin inhibitor targeting idiopathic pulmonary fibrosis. BMJ Open Respir Res 12:e003038. https:\/\/doi.org\/10.1136\/bmjresp-2024-003038","journal-title":"BMJ Open Respir Res"},{"key":"954_CR85","doi-asserted-by":"publisher","first-page":"2002559","DOI":"10.1183\/13993003.02559-2020","volume":"57","author":"N Hirani","year":"2021","unstructured":"Hirani N, MacKinnon AC, Nicol L et al (2021) Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis. Eur Respir J 57:2002559. https:\/\/doi.org\/10.1183\/13993003.02559-2020","journal-title":"Eur Respir J"},{"key":"954_CR86","doi-asserted-by":"publisher","first-page":"115163","DOI":"10.1016\/j.isci.2026.115163","volume":"29","author":"S Song","year":"2026","unstructured":"Song S, Liu W, Wang S et al (2026) Progress in siRNA therapy and delivery platforms for osteoarthritis. iScience 29:115163. https:\/\/doi.org\/10.1016\/j.isci.2026.115163","journal-title":"iScience"},{"key":"954_CR87","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s13287-025-04614-w","volume":"16","author":"F Wang","year":"2025","unstructured":"Wang F, Xie C, Wang X (2025) Mesenchymal stem cell therapies for ARDS: translational promise and challenges. Stem Cell Res Ther 16:504. https:\/\/doi.org\/10.1186\/s13287-025-04614-w","journal-title":"Stem Cell Res Ther"},{"key":"954_CR88","doi-asserted-by":"publisher","first-page":"102715","DOI":"10.1016\/j.omtn.2025.102715","volume":"36","author":"Y Shahsavandi","year":"2025","unstructured":"Shahsavandi Y, Banaeian F, Jafarinia M et al (2025) miRNAs from mesenchymal-stem-cell-derived extracellular vesicles: Emerging players in regenerative medicine and disease therapy. Mol Ther Nucleic Acids 36:102715. https:\/\/doi.org\/10.1016\/j.omtn.2025.102715","journal-title":"Mol Ther Nucleic Acids"},{"key":"954_CR89","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/pharmaceutics16121584","volume":"16","author":"R Fern\u00e1ndez-Garc\u00eda","year":"2024","unstructured":"Fern\u00e1ndez-Garc\u00eda R, Fraguas-S\u00e1nchez AI (2024) Nanomedicines for pulmonary drug delivery: overcoming barriers in the treatment of respiratory infections and lung cancer. Pharmaceutics 16:1584. https:\/\/doi.org\/10.3390\/pharmaceutics16121584","journal-title":"Pharmaceutics"},{"key":"954_CR90","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/applmicrobiol5040149","volume":"5","author":"PA Idowu","year":"2025","unstructured":"Idowu PA, Mbambalala L, Akinmoladun OF, Idowu AP (2025) Gut microbiome modulation by probiotics: implications for livestock growth performance and health\u2014narrative review. Appl Microbiol 5:149. https:\/\/doi.org\/10.3390\/applmicrobiol5040149","journal-title":"Appl Microbiol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00954-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:01:56Z","timestamp":1792533716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00954-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00954-3","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"24 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}